Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
-14.96%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$259B
AUM Growth
-$50.1B
Cap. Flow
-$2.37B
Cap. Flow %
-0.92%
Top 10 Hldgs %
21.65%
Holding
3,565
New
266
Increased
1,459
Reduced
1,410
Closed
322

Top Sells

1
BIDU icon
Baidu
BIDU
$302M
2
CSCO icon
Cisco
CSCO
$286M
3
ABBV icon
AbbVie
ABBV
$261M
4
NVDA icon
NVIDIA
NVDA
$210M
5
GM icon
General Motors
GM
$210M

Sector Composition

1 Technology 23.58%
2 Healthcare 13.98%
3 Financials 12.35%
4 Consumer Discretionary 10.53%
5 Industrials 8.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PBYI icon
3276
Puma Biotechnology
PBYI
$253M
-99,587
Closed -$308K
PINE
3277
Alpine Income Property Trust
PINE
$219M
-31,129
Closed -$582K
PKOH icon
3278
Park-Ohio Holdings
PKOH
$303M
-30,317
Closed -$487K
PLRX icon
3279
Pliant Therapeutics
PLRX
$114M
-81,824
Closed -$619K
PLSE icon
3280
Pulse Biosciences
PLSE
$1.02B
-36,567
Closed -$186K
PPTA
3281
Perpetua Resources
PPTA
$1.98B
-43,212
Closed -$201K
PRLD icon
3282
Prelude Therapeutics
PRLD
$69.6M
-66,421
Closed -$490K
PSNL icon
3283
Personalis
PSNL
$465M
-145,874
Closed -$1.19M
PYXS icon
3284
Pyxis Oncology
PYXS
$118M
-16,163
Closed -$65K
QD
3285
Qudian
QD
$733M
-184,200
Closed -$217K
QMCO icon
3286
Quantum Corp
QMCO
$98.8M
-10,610
Closed -$495K
QNCX icon
3287
Quince Therapeutics
QNCX
$86.5M
-59,701
Closed -$363K
RCEL icon
3288
Avita Medical
RCEL
$115M
-73,768
Closed -$571K
RDY icon
3289
Dr. Reddy's Laboratories
RDY
$11.9B
-57,785
Closed -$644K
REKR icon
3290
Rekor Systems
REKR
$138M
-129,969
Closed -$588K
RNAC icon
3291
Cartesian Therapeutics
RNAC
$277M
-69,021
Closed -$3.02M
RPID icon
3292
Rapid Micro Biosystems
RPID
$120M
-22,324
Closed -$171K
RVP icon
3293
Retractable Technologies
RVP
$23.7M
-15,945
Closed -$75K
RVYL icon
3294
Ryvyl
RVYL
$8.63M
-4,052
Closed -$127K
SG icon
3295
Sweetgreen
SG
$1.06B
$0 ﹤0.01%
111,730
+74,522
+200%
SLDB icon
3296
Solid Biosciences
SLDB
$428M
-13,877
Closed -$266K
SMMT icon
3297
Summit Therapeutics
SMMT
$19.3B
-54,748
Closed -$178K
SMSI icon
3298
Smith Micro Software
SMSI
$15.5M
-27,537
Closed -$711K
SNSE icon
3299
Sensei Biotherapeutics
SNSE
$10.5M
-2,623
Closed -$133K
SPRO icon
3300
Spero Therapeutics
SPRO
$121M
-60,598
Closed -$516K